Related Experiment Video

Updated: Aug 14, 2026

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in

Thomas L Andresen1, Simon S Jensen, Robert Madsen

  • 1Department of Chemistry, Technical University of Denmark, Building 207, DK-2800 Lyngby, Denmark. than@kemi.dtu.dk

Journal of Medicinal Chemistry
|November 11, 2005
PubMed

Insights

Novel anticancer ether lipids (AELs) show promise for cancer treatment by overcoming red blood cell lysis limitations. Their cytotoxicity correlates with inhibiting Akt phosphorylation, suggesting a new therapeutic strategy.

Area of Science:

  • Medicinal Chemistry
  • Lipid Biology
  • Cancer Therapeutics

Background:

  • Clinical application of anticancer lipids is hindered by red blood cell lysis, necessitating advanced delivery systems.
  • Anticancer ether lipids (AELs) require novel formulations for safe intravenous administration.
  • Previous work demonstrated liposome-encapsulated masked AELs activated by phospholipase A2 in tumors.

Purpose of the Study:

  • Synthesize novel anticancer ether lipids (AELs).
  • Evaluate the biological activity and cytotoxicity of synthesized AELs against cancer cell lines.
  • Investigate the correlation between AELs, stereochemistry, and Akt phosphorylation inhibition.

Main Methods:

  • Synthesis of six novel anticancer ether lipids (AELs).
  • In vitro cytotoxicity assays using three different human cancer cell lines.
  • Assessment of AELs' ability to inhibit Akt phosphorylation.

Main Results:

  • Stereochemistry of the glycerol headgroup significantly impacts the cytotoxicity of AEL-2 and AEL-3.
  • AELs 1-4 demonstrated varying levels of cytotoxic activity against tested cancer cell lines.
  • A correlation was established between the cytotoxic efficacy of AELs and their capacity to inhibit Akt phosphorylation.

Conclusions:

  • Stereochemistry is a critical factor in designing potent anticancer ether lipids.
  • Inhibition of Akt phosphorylation is a potential mechanism underlying the cytotoxicity of these novel AELs.
  • These findings support the development of AELs as a promising class of anticancer drugs with improved delivery strategies.

More Related Videos

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Related Concept Videos

Asymmetric Lipid Bilayer01:35

Asymmetric Lipid Bilayer

Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...